Inquire Before Buying - Infectious Respiratory Disease Diagnostics Market Size, Share & Growth Report 2028

Global Infectious Respiratory Disease Diagnostics Market Research Report: Forecast (2023-2028)

Infectious Respiratory Disease Diagnostics Market - By Product Type (Instruments Consumables, Services), By Sample Type (Nasopharyngeal Swabs (NPS), Saliva, Anterior Nasal Region,......Blood Others), By Application (Covid-19, Influenza, RSV (Respiratory Syncytial Virus), Tuberculosis, Streptococcus Testing, Others), By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Others), By End-User (Hospitals, Diagnostic Laboratories, Physician Offices) and others Read more

Healthcare
May 2023
Pages 184
Report Format: PDF, Excel, PPT

Market Definition

Infectious respiratory diseases are generally caused by the spread of bacteria, viruses, or other pathogenic microbes through saliva & mucus when a person talks, sneezes, coughs, or even laughs, which can severely infect the respiratory system of an individual. With the growing cases of such diseases worldwide, especially among the elderly population, early & accurate diagnosis of the disease-causing pathogens is becoming increasingly crucial for administering appropriate therapies, initiating effective infection control measures, and minimizing the length of hospital stay. As a result, significant R&D investments are being directed toward introducing novel diagnostics & therapeutics to treat patients with infectious respiratory diseases.

Market Insights & Analysis: Global Infectious Respiratory Disease Diagnostics Market (2023-28)

The Global Infectious Respiratory Disease Diagnostics Market is expected to grow at a considerable CAGR during the forecast period, i.e., 2023-28. Respiratory infectious diseases like pneumonia, bronchitis, sinus infections, and laryngitis, among others, are the third leading cause of death and result in over 3 million deaths every year globally, cites WHO. The mounting prevalence of these illnesses owing to changing lifestyles, increasing adoption of advanced molecular therapeutics, rapidly rising elderly population, and various initiatives taken by governments & non-profit organizations across different countries worldwide toward minimizing the incidence of these diseases are the prime aspects projected to drive the Infectious Respiratory Disease Diagnostics Market through 2028.

Report Coverage	Details
Study Period	Historical Data: 2018-21
	Base Year: 2022
	Forecast Period: 2023-28
Regions Covered	North America: The US, Canada, Mexico
	South America: Brazil, Argentina, Rest of South America
	Europe: The UK, Germany, France, Spain, Italy, Rest of Europe
	Asia-Pacific: China, India, Japan, South Korea, Australia, Singapore, Rest of Asia-Pacific
	Middle East & Africa: Saudi Arabia, The UAE, South Africa, Rest of Middle East & Africa
Key Companies Profiled	Abacus Diagnostica Oy, Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company (BD), Biocartis, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher, F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Illumina, Inc., QIAGEN N.V., Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., PerkinElmer, Inc., Hologic Inc., Novacyt Group, Qiagen, Quidel Corporation, Seegene, Inc., SDI Diagnostics
Unit Denominations	USD Million/Billion

Get Your Free Sample Report Now!

More and more diagnostics kits, assays, tubes, reagents, & other consumables are being utilized increasingly owing to the growing cancer incidence worldwide. Healthcare firms are substantially investing in introducing new products for infectious respiratory disease diagnostics, as well as in the commercialization of multiplex tests for the simultaneous diagnosis of Respiratory Syncytial Virus (RSV), Covid-19, & influenza, as these illnesses have similar symptoms.

On 12 July 2021, Abbott Laboratories announced the launch of Panbio™ Covid-19 Antigen Self-Test in India for SARS-CoV-2 virus detection in adults & children with or without symptoms. This self-test that features a minimally invasive nasal swab and provides results in as early as 15 minutes without any instrumentation would cater to the ever-increased testing requirements of individuals at homes, offices, & clinics.

As multiplex testing allows for the simultaneous targeting of multiple genes, which helps minimize the time & cost incurred with traditional diagnostics, such as PCR, the need for its global commercialization is accelerating at a phenomenal pace. Additionally, the launch of new molecular diagnostic tests for SARS-CoV-2 detection, increasing utilization of self-test kits & point-of-care products, as well as rapid technological advancements that have enabled accurate, portable, & cost-effective diagnostics are other crucial aspects projected to stimulate the industry expansion, further enhancing the Global Infectious Respiratory Disease Diagnostics Market size over the coming years.

Introduction
1. Research Process
2. Assumption
3. Market Segmentation
4. Market Definition
Executive Summary
Global Infectious Respiratory Disease Diagnostics Market Trends & Insights
Global Infectious Respiratory Disease Diagnostics Market Regulation & Policy, By Country
Global Infectious Respiratory Disease Diagnostics Market Dynamics
1. Growth Drivers
2. Challenges
3. Impact Analysis
Global Infectious Respiratory Disease Diagnostics Market Hotspot and Opportunities
Global Infectious Respiratory Disease Diagnostics Market Outlook, 2018-2028F
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Product Type
    1. Instruments
    2. Consumables
    3. Services
  2. By Sample Type
    1. Nasopharyngeal Swabs (NPS)
    2. Saliva
    3. Anterior Nasal Region
    4. Blood
    5. Others
  3. By Application
    1. Covid-19
    2. Influenza
    3. RSV (Respiratory Syncytial Virus)
    4. Tuberculosis
    5. Streptococcus Testing
    6. Others
  4. By Technology
    1. Immunoassay
    2. Molecular Diagnostics
    3. Microbiology
    4. Others
  5. By End-User
    1. Hospitals
    2. Diagnostic Laboratories
    3. Physician Offices
  6. By Region
    1. North America
    2. South America
    3. Europe
    4. Middle East & Africa
    5. Asia-Pacific
  7. By Company
    1. Competition Characteristics
    2. Revenue Shares
    3. Competitor Placement in MarkNtel Advisor’s Quadrant
North America Infectious Respiratory Disease Diagnostics Market Outlook, 2018-2028F
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Product Type
  2. By Sample Type
  3. By Application
  4. By Technology
  5. By End-User
  6. By Country
    1. The US
    2. Canada
    3. Mexico
South America Infectious Respiratory Disease Diagnostics Market Outlook, 2018-2028F
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Product Type
  2. By Sample Type
  3. By Application
  4. By Technology
  5. By End-User
  6. By Country
    1. Brazil
    2. Argentina
    3. Rest of South America
Europe Infectious Respiratory Disease Diagnostics Market Outlook, 2018-2028F
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Product Type
  2. By Sample Type
  3. By Application
  4. By Technology
  5. By End-User
  6. By Country
    1. The UK
    2. Germany
    3. France
    4. Italy
    5. Spain
    6. Rest of Europe
Middle East & Africa Infectious Respiratory Disease Diagnostics Market Outlook, 2018-2028F
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Product Type
  2. By Sample Type
  3. By Application
  4. By Technology
  5. By End-User
  6. By Country
    1. The UAE
    2. Saudi Arabia
    3. South Africa
    4. Rest of Middle East & Africa
Asia-Pacific Infectious Respiratory Disease Diagnostics Market Outlook, 2018-2028F
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Product Type
  2. By Sample Type
  3. By Application
  4. By Technology
  5. By End-User
  6. By Country
    1. China
    2. Japan
    3. India
    4. South Korea
    5. Australia
    6. Singapore
    7. Rest of Asia-Pacific
Global Infectious Respiratory Disease Diagnostics Market Key Strategic Imperatives for Success and Growth
Competitive Outlook
1. Competition Matrix
  1. By Application Portfolio
  2. Brand Specialization
  3. Target Markets
  4. Target By Applications
  5. Research & Development
  6. Strategic Alliances
  7. Strategic Initiatives
2. Company Profiles (Business Description, By Application Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
  1. Abacus Diagnostica Oy
  2. Abbott Laboratories
  3. Agilent Technologies, Inc.
  4. Becton, Dickinson and Company (BD)
  5. Biocartis
  6. bioMérieux SA
  7. Bio-Rad Laboratories, Inc.
  8. Danaher Corporation
  9. F. Hoffmann-La Roche AG
  10. Koninklijke Philips N.V.
  11. Illumina, Inc.
  12. QIAGEN N.V.
  13. Siemens Healthcare GmbH
  14. Thermo Fisher Scientific Inc.
  15. PerkinElmer, Inc.
  16. Hologic Inc.
  17. Novacyt Group
  18. Qiagen
  19. Quidel Corporation
  20. Seegene, Inc.
  21. SDI Diagnostics
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO INQUIRE BEFORE BUYING THIS REPORT

Name *

Email ID *

Country *